STEINMAN LAWRENCE (CIK 1132679) reported 5 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2025-12-01). Recent activity: Buy KTTA (133,333 shares), Buy ATNF (44,959 shares), Buy ATNF (48,198 shares), Buy BCAB (23,500 shares), Buy ATNF (65,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-01 | Pasithea Therapeutics Corp. (KTTA) | Director | Buy | 133,333 | $100,000 |
| 2025-06-30 | 180 Life Sciences Corp. (ATNF) | Director | Buy | 44,959 | $0 |
| 2025-06-20 | 180 Life Sciences Corp. (ATNF) | Director | Buy | 48,198 | $0 |
| 2025-06-18 | BioAtla, Inc. (BCAB) | Director | Buy | 23,500 | $0 |
| 2025-02-21 | 180 Life Sciences Corp. (ATNF) | Director | Buy | 65,000 | $0 |
Source: SEC Form 4 filings · as of 2025-12-01